Breville Takes On Trumps Tariffs
PHG Stock | USD 26.39 0.01 0.04% |
Roughly 59% of Koninklijke Philips' investor base is looking to short. The analysis of overall sentiment of trading Koninklijke Philips NV stock suggests that many investors are alarmed at this time. The current market sentiment, together with Koninklijke Philips' historical and current headlines, can help investors time the market. In addition, many technical investors use Koninklijke Philips stock news signals to limit their universe of possible portfolio assets.
Koninklijke |
Breville is already responding to impending tariffs on goods manufactured in China for import into the US under the Trump administration, to get ahead of the game
Read at fnarena.com
Koninklijke Philips Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Koninklijke Philips can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Koninklijke Philips Fundamental Analysis
We analyze Koninklijke Philips' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Koninklijke Philips using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Koninklijke Philips based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Koninklijke Philips is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Koninklijke Philips Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Koninklijke Philips stock to make a market-neutral strategy. Peer analysis of Koninklijke Philips could also be used in its relative valuation, which is a method of valuing Koninklijke Philips by comparing valuation metrics with similar companies.
Peers
Koninklijke Philips Related Equities
BRKR | Bruker | 5.34 | ||||
ZIMV | ZimVie | 1.85 | ||||
STE | STERIS Plc | 1.66 | ||||
ITGR | Integer Holdings | 1.64 | ||||
GMED | Globus Medical | 1.58 | ||||
NARI | Inari Medical | 1.53 | ||||
BSX | Boston Scientific | 1.47 | ||||
CNMD | CONMED | 1.44 | ||||
NVCR | Novocure | 1.36 | ||||
EW | Edwards Lifesciences | 1.21 | ||||
SYK | Stryker | 1.16 | ||||
ABT | Abbott Laboratories | 1.15 | ||||
INSP | Inspire Medical | 0.77 | ||||
MDT | Medtronic PLC | 0.75 | ||||
BIO | Bio Rad | 0.58 | ||||
SNNUF | Smith Nephew | 0.57 | ||||
GKOS | Glaukos Corp | 0.43 | ||||
SNN | Smith Nephew | 0.67 | ||||
ZBH | Zimmer Biomet | 0.80 | ||||
PODD | Insulet | 1.72 |
Complementary Tools for Koninklijke Stock analysis
When running Koninklijke Philips' price analysis, check to measure Koninklijke Philips' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Koninklijke Philips is operating at the current time. Most of Koninklijke Philips' value examination focuses on studying past and present price action to predict the probability of Koninklijke Philips' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Koninklijke Philips' price. Additionally, you may evaluate how the addition of Koninklijke Philips to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |